ET-743

Author： Cvetkovic R.S.   Figgitt D.P.   Plosker G.L.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.62, Iss.8, 2002-01, pp. : 1185-1192

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Trabectedin: ET 743, Ecteinascidin 743, Yondelis

By  

Drugs in R&D, Vol. 4, Iss. 1, 2003-01 ,pp. : 75-81

Adis International

Access to resources Recommend Favorite

Trabectedin: Ecteinascidin 743, Ecteinascidin-743, ET 743, ET-743, NSC 684766

By Adis International Limited  

Drugs in R&D, Vol. 7, Iss. 5, 2006-01 ,pp. : 317-328

Adis International

Access to resources Recommend Favorite

ET-743: A Viewpoint by Etienne G.C. Brain

By Brain E.G.C.  

Drugs, Vol. 62, Iss. 8, 2002-01 ,pp. : 1193-1194

Adis International

Access to resources Recommend Favorite

Ecteinascidin 743 [ET-743] may play an important role in the treatment of soft tissue sarcomas and other cancers

By  

Inpharma, Vol. 1, Iss. 1240, 2000-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetic Meta-Analysis of Trabectedin (ET-743, Yondelis ® ) in Cancer Patients

By Juan Jose Perez-Ruixo   Zannikos Peter  

Clinical Pharmacokinetics, Vol. 46, Iss. 10, 2007-01 ,pp. : 867-884

Adis International

Access to resources Recommend Favorite